摘要 |
Disclosed is a method for treating nervous system deterioration associated with aging and Alzheimer's disease by administering a therapeutically-effective amount of dehydroepiandrosterone or its sulfate. Also disclosed is the co-administration of dehydroepiandrosterone or its sulfate and a potassium channel antagonist. The disclosure is also directed to pharmaceutical compositions containing dehydroepiandrosterone, alone or in combination with a potassium channel antagonist. Dehydroepiandrosterone is also shown to facilitate the growth of nervous system tissue, particularly in culture.
|